中国药物警戒 ›› 2013, Vol. 10 ›› Issue (11): 696-697.

• 医院药事管理与合理用药 • 上一篇    下一篇

1例伊立替康联合化学治疗致严重不良反应后的药学监护

沈正林,袁明清   

  1. 昆山市第一人民医院,江苏昆山 215300
  • 收稿日期:2013-06-18 修回日期:2016-03-09 出版日期:2013-11-08 发布日期:2016-03-09

Pharmaceutical Care for One Case of Severe Adverse Reaction Induced by Irinotecan Combined with Chemotherapy

SHEN Zheng-lin ,YUAN Ming-qing   

  1. Department of Pharmacy, First People's Hospital of Kunshan, Jiangsu Kunshan 215300, China
  • Received:2013-06-18 Revised:2016-03-09 Online:2013-11-08 Published:2016-03-09

PDF (PC)

341

摘要： 目的 探讨对化疗药物引起不良反应的患者开展药学监护的方法。方法 临床药师参与1例直肠癌患者应用伊立替康联合化疗出现严重不良反应的治疗,并进行药学干预、药学监护。结果 通过对症和对因治疗后,患者安全度过化疗期。结论 临床药师应加强药学监护,提高药物治疗的安全性和有效性。

关键词: 伊立替康, 药品不良反应, 药学监护, 临床药师

Abstract: Objective To explore and develop the method of pharmaceutical care for adverse drug reaction induced by chemotherapeutics. Methods Clinical pharmacists participated in the treatment of the severe adverse reaction induced by irinotecan combined with chemotherapy of 1 case of rectal cancer, and provided pharmaceutical intervention and pharmaceutical care for the patient. Results With symptomatic treatment and etiological treatment, the patient safely passed the period of chemotherapy. Conclusion Clinical pharmacists should strengthen pharmaceutical care, improving the safety and efficacy of drug treatment.

Key words: irinotecan, adverse drug reaction, pharmaceutical care, clinical pharmacists

中图分类号: